MarketLens
Sign Up

What Just Happened with uniQure's Earnings and FDA Update

7 months ago
SHARE THIS ON:

What Just Happened with uniQure's Earnings and FDA Update

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?

uniQure (QURE) shares rose 17.5% since its last earnings report 30 days ago, driven by investor optimism following the results. The stock's next move may hinge on upcoming clinical and regulatory upda...
Stock News•2 months ago

uniQure N.V. (QURE) Q2 2026 Earnings Call Transcript

uniQure reported Q2 2026 earnings, with revenue falling 15% YoY to $12.5M, missing consensus estimates, due to lower-than-expected sales of its gene therapy Hemgenix.
Stock News•2 months ago

uniQure Q2 Earnings Call Highlights

uniQure aligned with the FDA on an accelerated-approval pathway for AMT-130, its Huntington's gene therapy. The company remains on track to submit a BLA in Q3 2026.

Breaking News

View All →

Top Headlines

View More →
Stock News•31 minutes ago

Tesla's stock falls as Elon Musk leaves investors wanting more

Stock News•53 minutes ago

Meta's stock rises as investors glimpse an opportunity that could dwarf the ad business

Stock News•58 minutes ago

Q3 Earnings Beats for Meta, Tesla, IBM and T.I.

Stock News•59 minutes ago

Meta Q3: From Facebook To Muse, Strong Growth Makes This A Strong Buy

Stock News•1 hour ago

2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG